How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2
-
Narrated by:
-
By:
In Part 2 of this series of the KCNA2 & Rare Epilepsy Podcast, Dr. Nancy Musarra continues her conversation with Dr. Erika Gray, pharmacist and Chief Medical Officer of Toolbox Genomics, to explore how pharmacogenomics and genomics may help families make more informed treatment decisions.
This episode focuses on how the body processes anti-seizure medications, why some people break down medications too quickly or too slowly, how side effects and adverse drug reactions may happen, and how genomic insights may help guide conversations with doctors. Dr. Gray also explains how genomics can offer insight into sleep, histamine responses, nutrition, and other factors that may affect children and adults living with rare epilepsy and neurological conditions.
If you are a parent, caregiver, clinician, or someone living with a rare epilepsy, this episode offers practical and accessible information about using genomics to better understand the whole person, not just the diagnosis.
Learn more: Toolbox Genomics: https://www.toolboxgenomics.com/
KCNA2 Epilepsy Foundation: https://www.kcna2epilepsy.org/